Schizophrenia and Antipsychotics
We recommend
New Strategies in the Treatment of Schizophrenia
Schizophrenia was primarily associated with dopamine dysfunction. Previous and current treatments have mainly targeted the mesolimbic dopamine pathway in the CNS and D2 receptors. However, the cited review article primarily addresses newer treatment targets and strategies beyond the dopamine hypothesis.
Negative Symptoms of Schizophrenia and Their Assessment
Schizophrenia is a serious psychiatric disorder with a prevalence of up to 1%. It can manifest with…
Impact of the COVID-19 Pandemic on People with Schizophrenia Spectrum Disorders
The COVID-19 pandemic has a far-reaching impact on the physical and mental health of the global…
Articles on this topic
Cariprazine − a Cardiometabolically Friendly Antipsychotic
Part of the 63rd Czech-Slovak Psychopharmacological Conference, held online from January…
First Effective Pharmacotherapy Modality for Negative Symptoms in Schizophrenia
Negative symptoms of schizophrenia significantly limit the quality of life and overall…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Interesting links
Most read on this topic
- Negative Symptoms of Schizophrenia and Their Assessment
- New Strategies in the Treatment of Schizophrenia
- Cariprazine − a Cardiometabolically Friendly Antipsychotic
- First Effective Pharmacotherapy Modality for Negative Symptoms in Schizophrenia
- Impact of the COVID-19 Pandemic on People with Schizophrenia Spectrum Disorders
Journal on this topic
Related topic
Interesting links